Research
PTC Therapeutics Launches New Program to Support Research Projects in Rare, Genetic Disorders
PTC Therapeutics, Inc.
PR-M02-19-NI-008-3074Feb 05, 2019
Clinical Trials
John Theurer Cancer Center Leading Enrollment for Global Phase 2 WIZARD Study Evaluating DSP-7888 in Patients with Recurrent Glioblastoma
John Theurer Cancer Center
PR-M01-19-NI-086Jan 30, 2019
Drug Development
Trovagene Announces New Patent Issued for Combination of Onvansertib with Anti-Androgen Drugs to Treat Non-Metastatic and Metastatic Prostate Cancer
Trovagene
PR-M01-19-NI-073Jan 25, 2019
Collaboration
Philogen Announces Collaboration With Celgene
Philogen
PR-M01-19-NI-074Jan 25, 2019
FDA Approval
FDA Approves Use of 0.5 mL Dose of Fluzone® Quadrivalent (influenza vaccine) in Children as Young as 6 Months of Age
Sanofi
PR-M01-19-NI-070Jan 24, 2019